Augmedix vs Regeneron Pharmaceuticals
Side-by-side comparison of AI visibility scores, market position, and capabilities
San Francisco medical documentation company combining AI transcription with remote human scribes to produce EHR notes from physician-patient encounters in real time via smartphone or Glass.
About
Augmedix is a San Francisco-based medical documentation company that combines AI transcription technology with remote human scribes to document physician-patient encounters in real time, producing complete EHR notes that physicians review and sign. Physicians wear Google Glass or use a smartphone to stream audio and video of patient encounters to Augmedix's platform, where remote scribes observe and document the visit, supported by AI tools that transcribe speech and suggest note structures. This hybrid AI-plus-human model enables documentation quality and customization that pure AI solutions struggle to achieve for complex clinical encounters, while still dramatically reducing the time physicians spend on documentation. Augmedix serves large health systems and multispecialty groups, with customer deployments across hundreds of physicians. The company went public via merger with LifeSci Acquisition in 2020 and was subsequently acquired by Nuvation Bio. Augmedix competes with Nuance DAX, Suki, and traditional medical transcription services in the clinical documentation market.
Regeneron (REGN) reported $13.9B revenue in FY2024, up 7% YoY. Top biotech company. Dupixent franchise >$14B. Leaders in eye disease, immunology, oncology. HQ: Tarrytown, NY.
About
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company specializing in the discovery, development, and commercialization of medicines for serious diseases, headquartered in Tarrytown, New York. Founded in 1988 by Leonard Schleifer and George Yancopoulos, Regeneron developed its own proprietary drug discovery technology platform (VelociGene, VelocImmune) that has enabled the development of multiple breakthrough medicines. The company reported revenues of $13.9B in FY2024, up 7% year-over-year.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.